We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.
- Authors
Tirelli, U; Errante, D; Van Glabbeke, M; Teodorovic, I; Kluin-Nelemans, J C; Thomas, J; Bron, D; Rosti, G; Somers, R; Zagonel, V; Noordijk, E M
- Abstract
We report the results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group, which compared a chemotherapy regimen specifically devised for elderly patients, ie, etoposide, mitoxantrone, and prednimustine (VMP), versus the standard regimen of cyclophosphamide, doxorobucin, vincristine, and prednisone (CHOP) in patients older than 70 years of age with intermediate- and high-grade non-Hodgkin's lymphoma (NHL).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Vol 16, Issue 1, p27
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1998.16.1.27